| abstract |
IT REFERS TO A COMPOUND OF FORMULA (I) OR ITS SALT, WHERE "A" IS R1q (R3R60N) m (Z) NR2) n; WHEN m IS ZERO q IS 1 AND IF q IS ZERO m IS 1; Z ES C = O or SO2; n IS 1 WHEN Z IS C = O; m IS 1; X IS -NH-, -CH2- or -OCH2-; AND IT IS 2-IMIDAZOLINE, 2-OXAZOLINE, 2-THIAZOLINE, 4-IMIDAZOLE; R1 IS H, ALKYL, PHENYL, IF R1 IS H, m IS 1; R2, R3, and R60 ARE H, ALKYL, OR PHENYL; R4, R5, R6 AND R7 ARE H, ALKYL, -CF3, AMONG OTHERS. ALSO REFERS TO A COMPOUND OF FORMULA (a). A PREFERRED COMPOUND IS (N- [3- (4,5-DIHYDRO-1H-IMIDAZOL-2-ILMETOXI) -PHENYL] -METANSULFONAMIDE), AMONG OTHERS. IT ALSO REFERS TO A PROCEDURE FOR PREPARATION. COMPOUND I IS AN ALPHA 1A / AL-ADRENORECEPTOR AGONIST AND MAY BE USEFUL FOR THE TREATMENT OF URINARY INCONTINENCE, NASAL CONGESTION, PRIAPISM, DEPRESSION, ANXIETY |